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Infection with coronavirus results in the accumulation of genomic-sized mRNA and six to eight subgenomic mRNAs that
make up a 39 coterminal nested-set structure. Genome-length negative-strand RNA and subgenomic-length negative-strand
RNAs, each of which corresponds to each of the subgenomic mRNAs, also accumulate in infected cells. The present study
examined whether the genome-length negative-strand RNA serves as a template for subgenomic mRNA synthesis. Genome-
length replicative intermediate (RI) RNA was purified by two-dimensional gel electrophoresis of intracellular RNAs from cells
infected with mouse hepatitis virus. RNase A treatment of the purified genome-length RI resulted in the production of the
genome-length replicative form RNA, indicating that the genome-length RI included genome-length template RNA. RNase
protection assays using the purified genome-length RI and two probes, which corresponded to the 59 300-nt region of mRNA
6 and to the same region of mRNA 7, showed the presence of nascent leader sequence-containing subgenomic mRNAs in
the genome-length RI. These data demonstrated that the genome-length negative-strand RNA serves as a template for
subgenomic mRNA synthesis. © 2000 Academic Press
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nCoronavirus is an enveloped RNA virus containing a
large positive-strand genomic RNA. Coronavirus-infected
cells produce a genomic-sized mRNA, mRNA 1, and six
to eight species of successively smaller subgenomic
mRNAs, which form a 39 coterminal nested-set structure
1–3). Characteristics of the unique coronavirus nested-
et structure are that all the mRNAs are polyadenylated
t the 39-end; the messages are successively larger by
ne gene at the 59-end with only the 59-most gene on the
olycistron being translated; and each has a 60- to 90-
t-long leader sequence at the 59-end (4–6). The leader
equences are derived from the 59-end of genomic RNA
the only place on the genome where they are encoded)
nd, by an unknown type of discontinuous synthesis (7),
hey join the 59-ends of each of the messages at the
ntergenic regions. Infected cells also produce negative-
trand genomic RNA and subgenomic RNAs, each of
hich corresponds to one mRNA species (8). These
egative-strand RNAs contain a poly (U) sequence at the
9-end and an anti-leader sequence at the 39-end (9).
ike coronaviruses, cells infected with arteriviruses pro-
uce a 39 coterminal nested set of mRNAs with the
eader sequence at the 59-end of the mRNAs (10). Sub-
enomic negative-strand RNAs that correspond to each
f the subgenomic mRNAs are also produced in arteri-
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238irus-infected cells. Coronaviruses and arteriviruses are
lassified under the newly established order Nidovirales;
oth viruses probably use similar transcription strate-
ies.
One of the unsolved questions in nidovirus transcrip-
ion is whether the template for subgenomic mRNAs is of
enome length or subgenome length. Two major models
ave been proposed. One suggests that a genome-
ength negative-strand RNA serves as a template for all
he mRNAs (11), while the other model proposes that
ach negative-strand subgenomic RNA is a unique tem-
late for synthesis of the correspondingly sized sub-
enomic mRNA (8, 12–15). A study using mouse hepatitis
irus (MHV), a prototypic coronavirus, demonstrated that
arly in infection negative-strand genomic RNA, and not
egative-strand subgenomic RNA, is the template for
ubgenomic mRNA synthesis (16); this study did not
etermine the template late in infection.
Here we describe whether MHV negative-strand
enomic RNA is also the template for subgenomic mRNA
ynthesis late in infection. Previous studies of replicative
ntermediate (RI) RNAs in MHV-infected cells were based
n the detection of two different types of RI RNAs: sub-
enomic RIs and genome-length RI. After a short pulse of
adiolabeling, the subgenomic RIs (13) appear as six to
even discrete RNA bands when separated by using
ondenaturing agarose gel electrophoresis. The polarity
f these elongating RNAs in the subgenomic RIs has not
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239RAPID COMMUNICATIONbeen identified. The genome-length RI RNA appears as a
slowly migrating diffuse band on a nondenaturing elec-
trophoretic gel (11, 13). RNase A treatment of the ge-
nome-length RI RNA results in the production of replica-
tive-form (RF) RNA 1, which comigrates with mRNA 1 (11,
13), demonstrating that the nascent RNAs are elongating
on genome-length template RNA in the genome-length
RI. RNase T1 fingerprinting analysis showed that the
majority of elongating RNAs in the genome-length RI are
positive-sense (11), strongly indicating that the genome-
length RI RNA must contain a genome-length negative-
strand RNA template. Accordingly, if the negative-strand
genome-length MHV RNA is a template for subgenomic
mRNA synthesis, then all the subgenomic mRNAs are
likely to be elongating in a genome-length RI RNA.
To test for the possibility that subgenomic mRNAs are
elongating from the negative-strand genome-length MHV
RNA in the genome-length RI RNA, we first purified
genome-length RI RNA. DBT cells were infected with the
A59 strain of MHV at a multiplicity of infection of 20;
defective interfering RNAs were undetectable in this
stock of MHV (13). The MHV RNAs were radiolabeled
from 4 to 7 h postinfection (p.i.) with 32Pi in the presence
of actinomycin D as described previously (17). Intracel-
lular RNA was extracted at 7 h p.i. using the Totally RNA
kit (Ambion), treated with DNase I, and applied onto an
oligo-dT cellulose chromatography column. The RNA
fraction that did not bind to the oligo-dT cellulose was
collected; this step lowered the amount of poly (A)-con-
taining mature MHV mRNAs in the RNA preparation.
Then the RNA sample was applied to a two-dimensional
0.8% TBE (89 mM Tris, 89 mM boric acid, 2 mM EDTA)
agarose gel containing ethidium bromide (Fig. 1). We
hoped that the two-dimensional gel electrophoresis
FIG. 1. Two-dimensional gel electrophoresis of the poly(A)-minus frac
id not bind to oligo-dT cellulose were mixed with lambda HindIII mark
lectrophoresis. (A) Ethidium bromide staining of the gel after two-di
ibosomal RNAs (28S rRNA and 18S rRNA) are shown. (B) Autoradiogr
as excised from the gel and used for further study. The asterisk is a
ompletely removed by oligo-dT cellulose column chromatography, iswould efficiently separate genome-length RI RNA from tMHV subgenomic mRNAs. A strong diffuse radioactive
RNA signal, which migrated slower than the 24-kbp-long
lambda HindIII marker DNA fragment, was detected after
two-dimensional gel electrophoresis. The gel region that
migrated more slowly than the 24-kbp-long DNA frag-
ment was excised carefully (Fig. 1). Based on a previous
study of the genome-length RI (13), this region of the gel
should contain the genome-length RI.
We further separated the RNA in the gel slices under
different electrophoretic conditions to estimate the purity
and the properties of the gel-purified genome-length RI.
First we looked for contamination of subgenomic mRNAs
in the gel-purified genome-length RI by processing the
gel piece obtained after two-dimensional gel electro-
phoresis in a new, nondenaturing 0.8% TBE gel next to
32P-labled MHV intracellular RNAs (Fig. 2A). Electro-
phoresis of the purified gel piece resulted in a diffuse
slowly migrating signal whose migration pattern was
similar to the published MHV genome-length RI RNA (11,
13). The purified gel pieces did not contain MHV mRNAs
even after a long exposure of the gel (data not shown).
Next we examined the production of the RF1 RNA after
RNase A treatment of the purified gel pieces. The gel
piece was treated with RNase A (0.33 mg/ml) in a buffer
233 mM NaCl, 3.3 mM Tris–HCl, pH 7.4, 10 mM EDTA) for
min at room temperature. After RNase A treatment, the
el piece was soaked in TBE buffer for 10 min at room
emperature. Then the gel piece was placed into the well
f a 0.8% TBE agarose gel and electrophoresed along-
ide labeled MHV intracellular RNAs (Fig. 2B), which
esulted in a single band that roughly comigrated with
RNA 1. Subgenomic RF RNAs were not detected even
fter much longer exposure of the gel. The migration of
his RNase-A-resistant band was very similar to that of
HV-intracellular RNAs. 32P-labled MHV-infected intacellular RNAs that
fragments and separated on 0.8% nondenaturing two-dimensional gel
nal gel electrophoresis. Lambda HindIII marker DNA fragments and
he two-dimensional gel. The box region containing genome-length RI
ct of the gel electrophoresis. A low level of mRNA 7, which was not
own.tion of M
er DNA
mensio
am of t
n artifahe RF 1 RNA described previously (11, 13). We further
240 RAPID COMMUNICATIONconfirmed the presence of the genome-length RI RNA in
the purified gel piece under denaturing gel electrophore-
sis. RNAs were extracted from the gel-purified gel pieces
using the RNaid kit (BIO 101) and then separated using
denaturing formaldehyde gel electrophoresis (Fig. 2C).
We only detected a smeary signal, the size of which
ranged from genomic in length to less than the size of
mRNA 7; we saw no discrete MHV mRNAs. Incubation of
genome-length RI at 65°C for 10 min and subsequent
separation in a 0.8% TBE agarose gel also produced a
similar smeary RNA signal (data not shown). We inter-
preted this absence of discrete mRNAs with the pres-
ence of a smeary signal to mean that the smear repre-
sented nascent RNAs that were elongating in genome-
length RI. Other experiments showed poor recovery of
RNA molecules larger than mRNA 3 from a gel, while
recovery of small RNAs was excellent (unpublished
data). This reduced efficiency of large RNA recovery from
the first gel appears as a drop in signal above the size of
mRNA 3 in the second separation (Fig. 1C). We repeated
these experiments at least three times and obtained
consistent results. We purified genome-length RI without
contamination of any detectable level of MHV sub-
genomic mRNAs.
We used RNase protection assays to look for nascent
subgenomic mRNAs containing the leader sequence in
FIG. 2. Characterization of genome-length RI. (A) Nondenaturing
agarose gel electrophoresis of purified gel pieces isolated after two-
dimensional agarose gel electrophoresis (lane 2). Total intracellular
RNAs from MHV-infected cells (lane 1). (B) Nondenaturing agarose gel
electrophoresis of purified gel pieces after RNase A treatment (lane 2).
Total intracellular RNAs from MHV-infected cells (lane 1). (C) Agarose
gel electrophoresis of an RNA sample that was extracted from the
purified gel pieces under the denaturing condition (lane 2). Total intra-
cellular RNAs from MHV-infected cells (lane 1).the genome-length RI. For these assays, an excess oftwo nonradiolabeled negative-sense RNA probes, one
complementary to the 59 300-nt region of mRNA 6 (probe
1) and the other to the same region in mRNA 7 (probe 2),
were independently mixed with heat-denatured 32P-la-
beled purified genome-length RI. After hybridization and
subsequent RNase A and RNase T1 treatment, RNase-
resistant RNA fragments were detected on electro-
phoretic sequence gels. If leader-sequence-containing
subgenomic mRNA 6 elongates on the genome-length
RI, then the RNase protection assay using probe 1 and
purified radiolabeled genome-length RI should produce
a radiolabeled 300-nt-long RNA fragment (300-nt frag-
ment) that corresponds to the 59-end 300 nt of nascent
mRNA 6 (see Fig. 3A). In addition, two RNA bands of
approximately 70 and 240 nt long (240-nt fragment)
should be detected, the former corresponding to the
leader sequence of all the nascent mRNAs other than
mRNA 6 and the latter to the 59 240-nt region of the
mRNA 6 body sequence, which is found in nascent MHV
mRNAs from 1 through 5. Similar results were expected
for the RNase protection assay using probe 2; in this
case a 300-nt-long radiolabeled RNA fragment should
represent nascent leader-sequence-containing mRNA 7
(Fig. 3A). If only genome-length mRNA 1 elongates on
genome-length RI, then the RNase protection assays
using either probe should yield just a 70-nt-long band
and a 240-nt-long band.
Two PCR products, each corresponding to the most 59
300 nt of mRNA 6 and mRNA 7, were cloned into a TA
cloning vector (Invitrogen). Probe 1 and probe 2, the
nonradiolabeled negative-strand RNA transcripts, were
transcribed from cloned plasmids using the T7 mMES-
SAGE mMACHINE kit (Ambion). In a separate experi-
ment, 32P-labeled genome-length RI was prepared using
two-dimensional gel electrophoresis as described
above. RNAs were extracted from the gel pieces by using
the RNaid kit, heat denatured at 65°C for 10 min, and
quickly chilled on ice. Labeled RNAs were then applied
to an oligo-dT cellulose chromatography column. We
collected the RNA fraction that bound to the oligo-dT
cellulose, the poly(A)-containing fraction, and the fraction
that did not bind to the oligo-dT cellulose, the poly(A)-
minus fraction. We assumed that the poly(A)-containing
fraction included nascent poly(A)-containing mRNAs
elongating in the genome-length RI and mature mRNAs
that might be contaminating the purified genome-length
RI preparation; and we assumed that the poly(A)-minus
would include mostly nascent RNA molecules and pos-
sibly be contaminated with degraded mature MHV RNAs
that lacked the poly(A) sequence. We separately mixed
each of the RNA fractions with each of the probes and
performed the RNase protection using the RiboQuant kit
(Pharmingen), according to the manufacturer’s instruc-
tion. After RNase A and T1 treatment, the samples were
incubated with proteinase K and extracted using phenol–
chloroform, and the RNAs were precipitated with etha-
c
w
m
p
t
m
2
c
1
m
q
M
w and
241RAPID COMMUNICATIONnol. Finally the RNAs were applied to a 6% polyacrylami-
de–urea gel. Control assays combining 32P-labeled intra-
ellular RNAs from MHV-infected cells with probe 2 and
ith probe 1 both yielded the 300- and the 240-nt frag-
ents (Figs. 3B and 3C). Production of these two ex-
ected fragments demonstrated that this RNase protec-
ion assay could specifically distinguish mRNA 6 and
RNA 7 from intracellular viral mRNA species. The
40-nt fragment appeared as two closely migrating dis-
rete bands (Fig. 3B); a shorter exposure of Fig. 3C, lane
, also showed two closely migrating discrete bands
aking up the 240-nt fragment. The presence of se-
uence heterogeneity at the leader–body fusion site of
HV mRNA 6 (18) may be the reason for the two closely
migrating 240-nt fragments in the RNase protection as-
say using probe 2. However, the origin of two 240-nt
fragments in the RNase protection assay using probe 1
is unclear, because extensive sequence heterogeneity
does not exist at the leader–body fusion site of mRNA 7
(18). It is possible that the RNase protection assay did
not quantitatively reflect the actual amounts of individual
intracellular viral mRNA species. The RNase protection
assay using the poly(A)-minus fraction of the purified
genome-length RI and probe 1 as well as the same RNA
fraction and probe 2 both showed the 300-nt fragment
and the 240-nt fragment (Figs. 3B and 3C). In contrast,
neither the 300-nt nor the 240-nt fragment was detected
when the poly(A)-containing fraction of the purified ge-
nome-length RI was used in combination with probe 2 or
FIG. 3. RNase protection assay. (A) Schematic diagram of RNase prot
Shaded boxes represent the leader sequence. (B) RNase protectio
poly(A)-containing fraction of the purified genome-length RI (lane 2), a
marker (lane M). Probe 2 was used for RNase protection assay. The
arrowhead, respectively. (C) RNase protection assay using total intrace
purified genome-length RI (lane 2), and poly(A)-minus fraction of the pur
The 300-nt fragment and the 240-nt fragment are indicated by an arrowith probe 1. In three repeated experiments, we consis-tently detected 300- and 240-nt fragments using the
poly(A)-minus fraction, while these bands were underde-
tectable or detected at a very low level using the poly(A)-
containing fraction.
If the purified genome-length RI were contaminated
with a large amount of mRNA 6 and mRNA 7, then we
should have detected the 300-nt-long fragment in the
poly(A)-containing fraction. The underdetectable levels of
the 300-nt-long fragment and the 240-nt fragment in the
poly(A)-containing fraction indicated that contamination
with mRNAs was very low in the gel-purified genome-
length RI. Consistent with RNase protection assay data,
contamination of mature MHV subgenomic mRNAs in
purified genome-length RI was at an underdetectable
level when purified genome-length RI was separated by
agarose gel electrophoresis (Fig. 2). In contrast, we
clearly detected the 300-nt fragment in the poly(A)-minus
fraction with either probe 1 or probe 2. As discussed
above, this 300-nt fragment could be produced from
nascent leader-sequence-containing mRNA 6 and mRNA
7 and/or from degraded MHV RNAs lacking the poly(A)
sequence that might be residually present in the purified
genome-length RI. Our preparation of MHV intracellular
RNA showed minimal RNA degradation (Fig. 2A); there-
fore, in our RNase protection assays we think that the
possibility that the 300-nt fragment was solely produced
from contaminating degraded mRNAs is highly unlikely.
More likely, the 300-nt fragment in the poly(A)-minus
fraction was produced from nascent subgenomic mRNA
assay. Binding sites of probe 1 and probe 2 to MHV mRNAs are shown.
ay using total intracellular RNA from MHV-infected cells (lane 1),
(A)-minus fraction of the purified genome-length RI (lane 3). RNA size
fragment and the 240-nt fragment are indicated by an arrow and an
NA from MHV-infected cells (lane 1), poly(A)-containing fraction of the
nome-length RI (lane 3). Probe 1 was used for RNase protection assay.
an arrowhead, respectively.ection
n ass
nd poly
300-nt
llular R
ified ge6 and mRNA 7, both of which contain the leader se-
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ing mRNAs 6 and 7, which are shorter than 300 nt in
length, should produce a smeared RNA signal in the
RNase protection assay. We could not detect the ex-
pected smeared RNA signals, so we supposed that the
signal was too low to be detected under the present
experimental conditions; in both autoradiograms, gels
were exposed to X-ray films for 3 weeks, and further
exposure had little effect on signal detection. RNase A
treatment of the gel-purified genome-length RI produced
RF 1 (Fig. 2B), and the RNase protection assay demon-
strated the presence of nascent leader-sequence-con-
taining subgenomic mRNAs in the genome-length RI.
Apparently, leader-sequence-containing subgenomic
mRNAs were produced from the genome-length nega-
tive-strand RNA in the genome-length RI. These data are
consistent with the model of coronavirus discontinuous
transcription (7, 11), which involves fusion of a leader
equence to every mRNA body during subgenomic
RNA synthesis.
The characteristics of the genome-length RI that we
escribed here agree with earlier analyses of MHV ge-
ome-length RI (11, 13). Sawicki and Sawicki (13) de-
scribed a slowly migrating genome-length RI during elec-
trophoresis of intracellular RNA from MHV-infected cells
in a nondenaturing gel. Their treatment of the gel fraction
containing the genome-length RI with RNaseA gave
mostly RF 1 and a low level of subgenome-length RF
RNAs, RF 2 and RF 3; RF 2 and RF 3 may well have been
due to the presence of contaminating subgenomic RIs in
the genome-length RI preparation. Baric et al. also
showed that genome-length RI RNA purified by Sepha-
rose 2B-CL column chromatography migrates slowly on
nondenaturing gels appearing as a smeared RNA and
produces RF 1 after RNase A treatment (11). The authors
compared RNase T1 fingerprinting patterns of column-
purified genome-length RIs under two conditions. Under
one condition the genome-length RI was digested with
RNase T1 without denaturation and under the other con-
dition the genome-length RI was digested after denatur-
ation of RNA. They found that T1 spots corresponding to
leader sequence and the leader–body fusion site for
subgenomic mRNAs appear as strong spots in the sam-
ple treated under the nondenaturing condition (11).
These data led the authors to propose that leader-se-
quence-containing subgenomic mRNAs elongate on ge-
nome-length RI. Although the previous study using the
column-purified genome-length RI (11) and the present
study used different experimental approaches to exam-
ine the nascent RNAs in the genome-length RI, the data
from these two independent studies indicated that MHV
genome-length negative-strand RNA is the template RNA
for subgenomic mRNA synthesis. We showed that neg-
ative-strand genomic RNA is the template for sub-
genomic mRNA synthesis early in infection (16). Our new
data strongly support the idea that negative-strand pgenomic RNA is a template for subgenomic mRNA syn-
thesis throughout the infection.
RNase A treatment of MHV genome-length RI, in which
nascent subgenomic mRNAs are elongating on a ge-
nome-length negative-strand RNA, resulted in RF 1. In
contrast, alphaviruses, which produce a subgenomic
mRNA that corresponds to the 39-region of viral genome,
produce three RF RNAs after RNase A treatment of al-
phavirus RI RNA; with this virus, genome RNA and sub-
genomic RNA elongate on a genome-length negative-
strand RNA in its RI RNA (19). Why RNase A treatment of
coronavirus genome-length RI produces RF 1 but not
subgenome-length RFs is unknown.
Although the present study and the previous study (16)
established that negative-strand genomic RNA is a tem-
plate for MHV subgenomic mRNA synthesis throughout
the infection, these studies do not eliminate the possi-
bility that MHV subgenomic mRNA is also synthesized
from subgenomic negative-strand template RNA late in
infection. A number of studies aimed to test whether
positive-strand RNA synthesis occurs using subgenomic
negative-strand template RNA in cells infected with coro-
naviruses (8, 12–14) and with arterivirus (15), yet did not
provide direct evidence of positive-strand RNA elonga-
tion from the subgenomic-length negative-strand tem-
plate. Sawicki and Sawicki revealed the presence of
subgenomic RIs in MHV-infected cells (13), and their data
directly demonstrated elongation of nascent RNA on
subgenomic-length template in infected cells, however,
the polarity of the template RNA in the subgenomic RIs
was not described. It is interesting to note that sub-
genomic RIs appear as discrete RNA bands that comi-
grate with subgenomic RFs, which were produced after
RNase A treatment of subgenomic RIs (13); electro-
phoretic patterns of subgenomic RIs imply that sub-
genomic RI exists as a completely double-stranded form.
Because RI RNAs that are efficiently synthesizing nas-
cent RNA molecules appear as a diffuse RNA signal in
nondenaturing gels, multiple nascent RNAs may not be
produced in MHV subgenomic RIs. Instead, subgenomic
RIs may exist as complete double-stranded RNAs, in
which newly synthesized subgenome-length RNA of ei-
ther polarity hybridizes with its subgenomic-length tem-
plate RNA. Recently, Baric and Yount reported the kinetic
radiolabeling analysis of MHV intracellular RNAs (12).
They demonstrated that the incorporation of radioiso-
topes into a subgenomic RF RNA, RF 7, increases rapidly
during 5-min pulse-labeling of MHV-infected cells; MHV
RF RNAs were obtained after RNase treatment of 32P-
abeled MHV intracellular RNAs. The authors interpreted
hese data that the incorporation of radioisotopes into
ascent positive-strand RNAs, which are elongating on
ubgenomic negative-strand template RNA in the sub-
enomic RI, is saturated quickly. They also showed the
radual increase of the RF 7 radioactivity after 5-min
ulse-labeling, which they interpreted to represent the
11
1
1
1
1
1
1
1
1
243RAPID COMMUNICATIONsynthesis of a constant and low level of subgenomic
negative-strand RNA, which is used as a template for
subgenomic mRNA synthesis. These interpretations of
the data led the authors to claim that nascent positive-
strand RNAs are elongating on subgenomic negative-
strand template RNA in the subegenomic RI (12). How-
ever, their data can be interpreted differently such that
subgenomic RIs are continuously produced efficiently in
infected cells, whereas many of them are quickly de-
graded. Because subgenomic RIs may exist as complete
double-stranded RNAs, subgenomic RIs can be an ex-
cellent interferon inducer; efficient accumulation of sub-
genomic RIs in infected cells may elicit the interferon
activation pathway. It is not surprising that MHV has
developed a mechanism that degrades most sub-
genomic RIs to inhibit double-strand RNA accumulation
in infected cells. None of the published studies demon-
strated the polarity of nascent RNAs elongating on sub-
genomic RIs in nidovirus-infected cells, hence it is pos-
sible that nascent negative-strand RNAs are elongating
on subgenomic RIs. The data presented by Baric and
Yount (12) do not exclude the possibility that subgenomic
negative-strand RNA is elongating in the subgenomic RI
RNA, which is unstable in infected cells.
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